Xellia Pharmaceuticals Email Format

Pharmaceutical ManufacturingCopenhagen, Denmark1001-5000 Employees

Xellia Pharmaceuticals is a specialty pharmaceutical company and a global leader in providing anti-infective treatments and other critical care therapies for serious and often life-threatening conditions. Xellia has an extensive heritage in developing, manufacturing, and commercializing anti-infective products.

Headquartered in Copenhagen, Denmark, and owned by Novo Holdings A/S, Xellia Pharmaceuticals has more than 1400 employees globally, including state-of-the-art manufacturing sites in China, Denmark, and Hungary. Our strong market position is built on more than 120 years of pharmaceutical industry experience.

Sign up for free to view info

Company overview Employee directory